Mast Cells and Pulmonary Hypertension in Rats
Author Information
Author(s): Dahal Bhola K, Kosanovic Djuro, Kaulen Christina, Cornitescu Teodora, Savai Rajkumar, Hoffmann Julia, Reiss Irwin, Ghofrani Hossein A, Weissmann Norbert, Kuebler Wolfgang M, Seeger Werner, Grimminger Friedrich, Schermuly Ralph T
Primary Institution: University of Giessen Lung Centre (UGLC), Giessen, Germany
Hypothesis
Do mast cells contribute to the development of pulmonary hypertension in monocrotaline-injected rats?
Conclusion
Mast cells accumulate and activate in the lungs, contributing to the development of pulmonary hypertension in monocrotaline-injected rats.
Supporting Evidence
- Mast cells were found to be significantly increased in the lungs of IPAH patients compared to healthy donors.
- Perivascular mast cells were predominantly degranulated in both IPAH patients and monocrotaline-injected rats.
- Pharmacological inhibition of mast cell degranulation improved hemodynamics in the preventive approach but not in the therapeutic approach.
Takeaway
Mast cells are like little helpers in our lungs, but when they get too active, they can cause problems like high blood pressure in the lungs.
Methodology
The study examined lung tissues from IPAH patients and monocrotaline-injected rats, measuring mast cell counts and their activation status, along with hemodynamic assessments.
Limitations
The therapeutic approach did not yield beneficial effects in established pulmonary hypertension.
Participant Demographics
Among the IPAH patients, six were male and four were female.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website